166 related articles for article (PubMed ID: 37779754)
1. Dermatomyositis Flare-Up Following the SARS-CoV-2 Vaccine: A Case Report and Literature Review.
Ryad R; Osman A; Almusa A; Gerges P; Sumbul-Yuksel B
Cureus; 2023 Aug; 15(8):e44324. PubMed ID: 37779754
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports.
Vutipongsatorn K; Isaacs A; Farah Z
J Med Case Rep; 2022 Jan; 16(1):57. PubMed ID: 35094715
[TBL] [Abstract][Full Text] [Related]
3. Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination.
Gouda W; Albasri A; Alsaqabi F; Al Sabah HY; Alkandari M; Abdelnaby H
J Korean Med Sci; 2022 Feb; 37(5):e32. PubMed ID: 35132838
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
Jeon YH; Lim DH; Choi SW; Choi SJ
Rheumatol Int; 2022 Apr; 42(4):743-748. PubMed ID: 34797392
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
Avci E; Abasiyanik F
J Autoimmun; 2021 Dec; 125():102745. PubMed ID: 34781161
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report.
Syrmou V; Liaskos C; Ntavari N; Mitsimponas K; Simopoulou T; Alexiou I; Vlychou M; Katsiari CG; Bogdanos DP
Immunol Res; 2023 Aug; 71(4):537-546. PubMed ID: 36928720
[TBL] [Abstract][Full Text] [Related]
9. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
Front Public Health; 2021; 9():778964. PubMed ID: 34888290
[No Abstract] [Full Text] [Related]
10. When a Painful Rash Keeps Recurring: A Case of Seronegative Amyopathic Dermatomyositis Without Neurological Sequelae.
Harazeen A; Walter B; Li X; Patel C
Cureus; 2023 Jul; 15(7):e42727. PubMed ID: 37654955
[TBL] [Abstract][Full Text] [Related]
11. New-onset dermatomyositis following COVID-19: A case report.
Shimizu H; Matsumoto H; Sasajima T; Suzuki T; Okubo Y; Fujita Y; Temmoku J; Yoshida S; Asano T; Ohira H; Ejiri Y; Migita K
Front Immunol; 2022; 13():1002329. PubMed ID: 36353621
[TBL] [Abstract][Full Text] [Related]
12. A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination - a Case Report.
Wang S; Noumi B; Malik F; Wang S
SN Compr Clin Med; 2023; 5(1):18. PubMed ID: 36530960
[TBL] [Abstract][Full Text] [Related]
13. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
[TBL] [Abstract][Full Text] [Related]
14. A case series of dermatomyositis following SARS-CoV-2 vaccination.
Chan AR; Cohen Tervaert JW; Redmond D; Yacyshyn E; Ferrara G; Hwang PM; Osman M; Gniadecki R
Front Med (Lausanne); 2022; 9():1013378. PubMed ID: 36419787
[TBL] [Abstract][Full Text] [Related]
15. Dermatomyositis post vaccine against SARS-COV2.
Camargo Coronel A; Jiménez Balderas FJ; Quiñones Moya H; Hernández Zavala MR; Mandinabeitia Rodríguez P; Hernández Vázquez JR; Zamora Zarco S; Aguilar Castillo SJ
BMC Rheumatol; 2022 Apr; 6(1):20. PubMed ID: 35361289
[TBL] [Abstract][Full Text] [Related]
16. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
17. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
King ER; Towner E
Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
[TBL] [Abstract][Full Text] [Related]
18. A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination.
Kim S; Jung J; Cho H; Lee J; Go H; Lee JH
Pediatr Nephrol; 2023 Jan; 38(1):299-302. PubMed ID: 35854121
[TBL] [Abstract][Full Text] [Related]
19. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
[TBL] [Abstract][Full Text] [Related]
20. Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report.
Herath HMMTB; Keragala BSDP; Pahalagamage SP; Janappriya GHCC; Kulatunga A; Gunasekera CN
J Med Case Rep; 2018 Mar; 12(1):83. PubMed ID: 29571300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
